POMBILITI
Live / Registered — Registered (as of 23 Apr 2024)
What this means for you
Registered since 23 Apr 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98119869
- Registration number
- 7367201
- Mark type
- Stylized text
- Filed
- 07 Aug 2023
- Published for opposition
- 06 Feb 2024
- Registered
- 23 Apr 2024
- Attorney of record
- Matthew Hintz, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Pompe disease; Pharmaceutical preparations for the treatment of genetic diseases; Enzyme replacement therapy preparations for medical purposes
Owner
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
- AMICUS THERAPEUTICS, INC., Philadelphia, PA, US
Prosecution history
- 23 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 23 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 06 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Feb 2024 — PUBLISHED FOR OPPOSITION
- 17 Jan 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Dec 2023 — NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
- 28 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Dec 2023 — USE AMENDMENT ACCEPTED
- 27 Dec 2023 — ASSIGNED TO EXAMINER
- 19 Oct 2023 — AMENDMENT TO USE PROCESSING COMPLETE
- 19 Oct 2023 — USE AMENDMENT FILED
- 18 Oct 2023 — TEAS AMENDMENT OF USE RECEIVED
- 05 Sept 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Aug 2023 — NEW APPLICATION ENTERED